Autologous Hair Follicle Derived Mesenchymal Stem Cell Suspension to Treat AGA

Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Dec 19, 2022

Keywords

ClinConnect Summary

Androgenic alopecia (AGA) is the most common form of hair loss. It starts in adolescence and is mainly characterized by progressive hair follicle miniaturization. In the continuous hair cycle process, the pathological hair follicle mesenchymal niche in the hair loss area is continuously damaged. The mesenchymal cells are continuously consumed, resulting in functional disorder, gradually losing the ability to induce the proliferation and differentiation of hair follicle epidermal cells to form hair follicles. This process eventually leads to the complete miniaturization and loss of hair foll...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of Androgenic alopecia
• • AGA classification include：The Norwood grade for male hair loss was II-V, and the Ludwig grade for female hair loss was I-III
• Exclusion Criteria:
• • (1) Using medications or supplements, including finasteride, dutasteride, ketoconazole, minoxidil or any other hormonal products, that can affect hair growth;
• • (2) Patients with severe systemic diseases, immune diseases, endocrine diseases and nervous system diseases;
• • (3) Patients with head skin infection, allergic disease and malignant tumor

Trial Officials